Funding newsPublished December 22, 2025

Spica Therapeutics Secures $1.2M Grant

Recently funded · $1.2M GrantManufacturing

Get the full Spica Therapeutics company profile

Access contacts, investors, buying signals & more

Spica Therapeutics has secured $1.2 million in its latest funding round, the company announced today. This capital infusion marks a significant milestone for the biotechnology firm as it continues to advance its innovative research and development efforts. The investment underscores investor confidence in Spica Therapeutics' scientific approach and its potential to develop groundbreaking treatments for challenging diseases. This successful fundraising effort provides the necessary resources to propel the company's strategic objectives forward.

Spica Therapeutics is dedicated to pioneering novel macrophage-targeted therapeutics. Its core mission is to address the unmet needs of patients across multiple disease areas by leveraging advanced scientific understanding of macrophage biology. The company's research focuses on developing highly targeted therapies that could offer new hope for conditions currently lacking effective treatment options, aiming to improve patient outcomes through precision medicine.

The $1.2 million in funding will be instrumental in accelerating Spica Therapeutics' strategic initiatives. The company plans to use the funds to expand its research capabilities, further develop its therapeutic pipeline, and support key operational growth. This investment is expected to enable Spica Therapeutics to reach critical development milestones, including preclinical studies and further platform optimization, thereby strengthening its position in the competitive biopharmaceutical landscape. The capital will also support the recruitment of specialized talent to bolster its scientific and operational teams.

This funding round positions Spica Therapeutics for continued expansion and progress in its mission to bring novel therapies to patients. The company is focused on leveraging this capital to drive innovation, broaden its scientific impact, and ultimately translate its pioneering research into tangible clinical solutions. Spica Therapeutics anticipates this investment will fuel its trajectory towards becoming a leader in macrophage-targeted therapeutics, with a long-term vision of transforming patient care in areas of high unmet medical need.

Other recently funded companies

View all

Guangdong Yimu Technology Co., Ltd.
Since its establishment, Guangdong Yimu Technology Co., Ltd. has issued 55 certificates of CCC and CQC in more than one year . The products released by the company from September 2018 to April 2019 are all innovative products , and there is no similar product in the market. As of April, a total of 4 corporate standards have been drafted . The company has applied for more than 12 invention and utility model patents in the past six months . The company's subsequent research and development products have signed initial release agreements with major platforms such as Global.com and Amazon . The company signed a cooperation agreement with Huazhong University of Science and Technology to form an industrialized landing in laser detection and sensor detection. The company is strongly supported by the local government of Xiantao, the factory is provided free of charge, and the tax reduction is optimal. Xiaomi Eco-Chain Company, Zhimi invests in and holds subsidiaries. Currently the company has offices in Beijing and Shenzhen. The company mainly has two business divisions, corporate service division and consumer division. The business division is engaged in the research and development, manufacturing and sales of power electronics and control panel products. The Consumer Business Unit was established in December 2018 and is mainly engaged in the research and development, manufacturing and sales of smart home products. The company's personnel are composed of DELTA, Topband, Nidec and other companies, all of whom have more than 10 years of experience. The company has a complete set of capabilities from industrial design to product design and organization of mass production, product sales, and after-sales. The company reserves more than ten technical patents within half a year, including the ability to cross-use patents with Huawei's instant heating equipment.

Other recent Grant rounds

Companies that recently closed a Grant round.

#	Company	Round	Amount	Date
1	Scanalytics Inc. United States	Grant	$1.3M	1mo ago
2	Daylight Solutions United States	Grant	$871.2K	1mo ago

Spica Therapeutics Secures $1.2M Grant

Other recently funded companies

Other recent Grant rounds

Investors

Similar recently funded companies